A detailed history of Gamma Investing LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gamma Investing LLC holds 5,433 shares of AZN stock, worth $350,102. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,433
Previous 4,546 19.51%
Holding current value
$350,102
Previous $355 Million 19.39%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$76.67 - $87.62 $68,006 - $77,718
887 Added 19.51%
5,433 $423 Million
Q2 2024

Jul 02, 2024

BUY
$66.81 - $80.83 $65,941 - $79,779
987 Added 27.73%
4,546 $355 Million
Q1 2024

Apr 05, 2024

BUY
$61.03 - $69.57 $37,777 - $43,063
619 Added 21.05%
3,559 $241 Million
Q4 2023

Feb 01, 2024

BUY
$61.89 - $69.28 $181,956 - $203,683
2,940 New
2,940 $196 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.